Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/30851897http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/30851897http://www.w3.org/2000/01/rdf-schema#comment"The aberrant expression of ceroid-lipofuscinosis 3 (CLN3) has been reported in a variety of human malignancies. However, the role of CLN3 in the progression and prognosis of hepatocellular carcinoma (HCC) remains unknown. In this study, we found that CLN3 was frequently upregulated in HCC clinical samples and HCC-derived cell lines and was significantly correlated with an APF serum level ≥20 μg/L, a tumour size ≥5 cm, multiple tumours, and the absence of encapsulation. Kaplan-Meier showed that CLN3 upregulation predicted shorter recurrence-free survival (RFS) and overall survival (OS) time in HCC patients. Cox regression analysis revealed that CLN3 upregulation was an independent risk factor for RFS and OS. A functional study demonstrated that the knockdown of CLN3 expression profoundly suppressed the growth and metastasis of HCC cells both in vitro and in vivo. Mechanistic investigation revealed that the EGFR/PI3K/AKT pathway was essential for mediating CLN3 function. In conclusion, our results provide the first evidence that CLN3 contributes to tumour progression and metastasis and offer a potential prognostic predictor and therapeutic target for HCC."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.org/dc/terms/identifier"doi:10.1016/j.suronc.2018.12.003"xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Chen F."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Chen C."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Luo H."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Tian Y."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Sun L."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Yu J."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Xu Y."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Wang H."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Xie Z."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Wang K."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Zeng Y."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Shen Z."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Li P.P."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/author"Shu R."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/name"Surg Oncol"xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/pages"180-189"xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/title"Overexpression of CLN3 contributes to tumour progression and predicts poor prognosis in hepatocellular carcinoma."xsd:string
http://purl.uniprot.org/citations/30851897http://purl.uniprot.org/core/volume"28"xsd:string
http://purl.uniprot.org/citations/30851897http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/30851897
http://purl.uniprot.org/citations/30851897http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/30851897
http://purl.uniprot.org/uniprot/#_B4DFF3-mappedCitation-30851897http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30851897
▶